Compare DSL & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DSL | QDEL |
|---|---|---|
| Founded | 2013 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2013 | 2022 |
| Metric | DSL | QDEL |
|---|---|---|
| Price | $10.88 | $12.40 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $28.25 |
| AVG Volume (30 Days) | 513.4K | ★ 2.3M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | ★ 11.95% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.49 | $9.92 |
| 52 Week High | $12.67 | $35.58 |
| Indicator | DSL | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 44.01 | 50.70 |
| Support Level | N/A | $10.39 |
| Resistance Level | $11.22 | $12.85 |
| Average True Range (ATR) | 0.13 | 0.97 |
| MACD | -0.03 | 0.34 |
| Stochastic Oscillator | 46.92 | 85.67 |
DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.